AXL and pulmonary arterial hypertension: HIF1A is a master regulator of oxygen homeostasis with augmented expression in PAH [128–131], while AXL is a key regulator of endothelial BMPR2 signaling, whose loss-of-function mutations is the most common genetic cause of PAH [132, 133].